CNMD CONMED Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CNMD

Price (delayed)

$33.55

Market cap

$1.01B

P/E Ratio

18.95

Dividend/share

$0.8

EPS

$1.77

Enterprise value

$1.84B

?
Relative Growth: Rel. Growth: 49
Relative Strength: Rel. Strength: 16
Relative Valuation: Rel. Valuation: 68
Relative Profitability: Rel. Profitability: 47

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, ...

Highlights
The stock's price to earnings (P/E) is 51% less than its 5-year quarterly average of 37.4 and 12% less than its last 4 quarters average of 21.0
CNMD's revenue is up by 4.1% year-on-year
The net income has dropped by 54% year-on-year but it is up by 17% since the previous quarter
CNMD's EPS has shrunk by 54% YoY but it is up by 16% QoQ
CNMD's quick ratio is down by 2.2% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.conmed.com
Peers: BSX MDT TFX SYK

Key stats

What are the main financial stats of CNMD

CNMD stock price

How has the CONMED stock price performed over time
Intraday
3.1%
1 week
-2.95%
1 month
-9.88%
1 year
-35.07%
YTD
-17.36%
QTD
-5.12%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.37B
Gross profit
$756.17M
Operating income
$111.66M
Net income
$54.85M
Gross margin
55.2%
Net margin
4%
The company's net margin has shrunk by 56% YoY but it rose by 18% QoQ
The net income has dropped by 54% year-on-year but it is up by 17% since the previous quarter
The operating margin has declined by 41% year-on-year but it has grown by 9% since the previous quarter
The operating income has declined by 38% year-on-year but it has increased by 9% since the previous quarter

Price vs fundamentals

How does CNMD's price correlate with its fundamentals

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
CNMD P/E details
P/E
18.95
P/B
1.02
P/S
0.75
EV/EBIT
16.44
EV/EBITDA
14.26
EV/Sales
1.34
CNMD's EPS has shrunk by 54% YoY but it is up by 16% QoQ
The stock's price to earnings (P/E) is 51% less than its 5-year quarterly average of 37.4 and 12% less than its last 4 quarters average of 21.0
The stock's price to book (P/B) is 71% less than its 5-year quarterly average of 3.4 and 24% less than its last 4 quarters average of 1.3
CNMD's equity is up by 4.1% YoY
CNMD's P/S is 70% less than its 5-year quarterly average of 2.4 and 27% less than its last 4 quarters average of 1.0
CNMD's revenue is up by 4.1% year-on-year

Efficiency

How efficient is CONMED business performance
The ROE has plunged by 57% YoY but it has grown by 15% from the previous quarter
CNMD's return on assets has dropped by 54% year-on-year but it is up by 20% since the previous quarter
CNMD's ROS is down by 41% YoY but it is up by 9% QoQ
CNMD's return on invested capital is down by 37% year-on-year but it is up by 8% since the previous quarter

Dividends

What is CNMD's dividend history
Dividend details
DPS
$0.8
Dividend yield
2.38%
Payout ratio
45.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did CONMED financials performed over time
CNMD's total assets is 78% greater than its total liabilities
The current ratio has grown by 7% from the previous quarter
CNMD's quick ratio is down by 2.2% QoQ
The company's debt is 15% lower than its equity
The company's debt to equity fell by 7% YoY but it rose by 4.9% QoQ
The company's debt fell by 3.5% YoY but it rose by 3.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.